(Q38832692)

6 September 2017

title

TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression (English)

1 reference

Corrigendum: TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression.

6 September 2017

1 reference

corrigendum / erratum

0 references

author

Yoshihide Hayashizaki

5

object named as

Yoshihide Hayashizaki

1 reference

6 September 2017

3

Takashi Suzuki

1 reference

6 September 2017

7

Yukio Homma

1 reference

6 September 2017

6

Tetsuya Fujimura

1 reference

6 September 2017

Ken-ichi Takayama

1

1 reference

6 September 2017

Aya Misawa

2

1 reference

6 September 2017

Kiyoshi Takagi

4

1 reference

6 September 2017

Satoru Takahashi

8

1 reference

6 September 2017

Tomohiko Urano

9

1 reference

6 September 2017

Satoshi Inoue

10

1 reference

6 September 2017

language of work or name

English

0 references

publication date

25 September 2015

1 reference

6 September 2017

published in

Nature Communications

1 reference

6 September 2017

volume

6

1 reference

6 September 2017

page(s)

8219

1 reference

6 September 2017

cites work

Chromatin and signaling

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Reversing DNA methylation: mechanisms, genomics, and biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

TET enzymes, TDG and the dynamics of DNA demethylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Molecular determinants of resistance to antiandrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Transcriptional network of androgen receptor in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Mechanisms of androgen-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Epigenetic regulation of cancer growth by histone demethylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Mechanism of the nuclear receptor molecular switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Chromatin remodeling and nuclear receptor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Nuclear receptor coactivators: master regulators of human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Deconstructing repression: evolving models of co-repressor action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

A peek into the complex realm of histone phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Unamplified cap analysis of gene expression on a single-molecule sequencer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

A promoter-level mammalian expression atlas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

The tumor suppressor protein HBP1 is a novel c-myc-binding protein that negatively regulates c-myc transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Model-based analysis of ChIP-Seq (MACS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Pioneer factors in hormone-dependent cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Integration of Regulatory Networks by NKX3-1 Promotes Androgen-Dependent Prostate Cancer Survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

The translational landscape of mTOR signalling steers cancer initiation and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Coordinated regulation of polycomb group complexes through microRNAs in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

MicroRNA expression profiles classify human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Causes and consequences of microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

The role of microRNA in castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

The role of miRNA-29 family in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

miR-29b regulates migration of human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

JAK-STAT blockade inhibits tumor initiation and clonogenic recovery of prostate cancer stem-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Perspectives on mTOR inhibitors for castration-refractory prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

CtBP2 modulates the androgen receptor to promote prostate cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Quantitative analysis of chromosome conformation capture assays (3C-qPCR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCOMMS9219

Prostate cancer: an enzalutamide antiandrogen withdrawal syndrome

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26404510

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Diverse roles of miR-29 in cancer (review).

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26404510

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NCOMMS9219

1 reference

Dimensions Publication ID

6 September 2017

0 references

1020428164

0 references

1 reference